International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 9 , ISSUE 4 ( October-December, 2016 ) > List of Articles

Original Article

Comparative Evaluation of Bioactive Synthetic NovaBone Putty and Calcified Algae-derived Porous Hydroxyapatite Bone Grafts for the Treatment of Intrabony Defects

Nitika N Bembi, Sumit Bembi, Jyoti Mago, Gurpreet Kaur Baweja, Parvinder Singh Baweja

Keywords : Bone grafts, Bone regeneration, Intrabony defects

Citation Information : Bembi NN, Bembi S, Mago J, Baweja GK, Baweja PS. Comparative Evaluation of Bioactive Synthetic NovaBone Putty and Calcified Algae-derived Porous Hydroxyapatite Bone Grafts for the Treatment of Intrabony Defects. Int J Clin Pediatr Dent 2016; 9 (4):285-290.

DOI: 10.5005/jp-journals-10005-1379

License: CC BY-NC 4.0

Published Online: 01-04-2019

Copyright Statement:  Copyright © 2016; The Author(s).


Introduction: To compare and evaluate clinically and radio-graphically the bone regeneration and the amount of bone fill in intrabony component of periodontal osseous defects through the osteoconductive and osteostimulative effect of bioactive synthetic NovaBone Putty - CMF and osteoconductive effect of calcified algae-derived porous hydroxyapatite Frios® Algi-pore® bone grafts. Materials and methods: Twenty-two sites in 11 patients, within the age range of 25 to 60 years, showing intrabony defects were selected according to split mouth design and divided into group I (Frios® Algipore®) and group II (NovaBone Putty - CMF). All the selected sites were assessed with the clinical and radiographic parameters like plaque index, gingival index (full mouth and site specific), sulcus bleeding index, probing pocket depth, clinical attachment level, gingival recession, and radiographic bone fill. All the clinical and radiographic parameter values obtained at different intervals (baseline, 3, and 6 months) were subjected to statistical analysis. Results: A statistically significant reduction in pocket depth of 2.55 ± 0.52 mm (group I), 2.64 ± 0.67 mm (group II) and gain in clinical attachment level of 7.55 ± 1.44 mm (group I), 7.55 ± 2.38 mm (group II) were recorded at the end of the study. A slight increase in gingival recession was observed. The mean percentage change in amount of radiographic bone fill of group II (71.34%) was more than group I (61.93%). Conclusion: Both NovaBone Putty - CMF and Frios® Algipore® improve healing outcomes and lead to a reduction of probing depth, a resolution of osseous defects, and a gain in clinical attachment, but radiographic observation found better results with NovaBone Putty. How to cite this article: Bembi NN, Bembi S, Mago J, Baweja GK, Baweja PS. Comparative Evaluation of Bioactive Synthetic NovaBone Putty and Calcified Algae-derived Porous Hydroxyapatite Bone Grafts for the Treatment of Intrabony Defects. Int J Clin Pediatr Dent 2016;9(4):285-290.

PDF Share
  1. Lindhe J, Lang NP, Karring T. Clinical periodontology and implant dentistry. 5th ed. Oxford: Blackwell Munksgaard Publishers; 2008. p. 542.
  2. Rosenberg E, Rose LF. Biologic and clinical considerations for autografts and allografts in periodontal regeneration therapy. Dent Clin North Am 1998 Jul;42(3):467-490.
  3. Aichelmann-Reidy ME, Yukna RA. Bone replacement grafts. Dent Clin North Am 1998 Jul;42(3):491-503.
  4. Nevins ML, Camelo M, Lynch SE, Schenk RK, Nevins M. Evaluation of periodontal regeneration following grafting intrabony defects with Bio-Oss collagen: a human histologic report. Int J Periodontics Restorative Dent 2003 Feb;23(1): 9-17.
  5. Park JS, Suh JJ, Choi SH, Moon IS, Cho KS, Kim CK, Chai JK. Effect of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 2001 Jun;72(6):730-740.
  6. Villaça JH, Novaes AB, Souza SL, Taba M Jr, Molina GO, Carvalho TL. Bioactive glass efficacy in the periodontal healing of intrabony defects in monkeys. Braz Dent J 2005;16(1): 67-74.
  7. Schopper C, Moser D, Wanschitz F, Watzinger F, Lagogiannis G, Spassova E, Ewers R. Histomorphologic findings on human bone samples six months after bone augmentation of the maxillary sinus with Algipore. J Long Term Eff Med Implants 1999;9(3):203-213.
  8. Silness J, Loe H. Periodontal disease in pregnancy (II): Correlation between oral Hygiene and periodontal conditions. Acta Odontol Scand 1964 Feb;22:121-135.
  9. Loe H, Sillness J. Periodontal disease in pregnancy (I): prevalence and severity. Acta Odontol Scand 1963 Dec;21: 533-551.
  10. Muhlemann HR, Son S. Gingival sulsus bleeding–a leading symptom in initial gingivitis. Helvetica Odontologica Acta 1971 Oct;15(2):105-113.
  11. Clark DC, Quee TC, Bergeron MJ, Chan EC, Lautar-Lemay C, de Gruchy K. Reliability of attachment level measurements using the cementoenamel junction and a plastic stent. J Periodontol 1987 Feb;58(2):115-118.
  12. Froum SJ, Weinberg MA, Tarnow D. Comparison of bioactive glass synthetic bone graft particles and open debridement in the treatment of human periodontal defects. A clinical study. J Periodontol 1998 Jun;69(6):698-709.
  13. Tonetti MS, Pini Prato G, Williams RC, Cortellini P. Periodontal regeneration of human infrabony defects. III. Diagnostic strategies to detect bone gain. J Periodontol 1993 Apr;64(4):269-277.
  14. Froum SJ, Kushner L, Stahl SS. Healing responses of human intraosseous lesions following the use of debridement, grafting and citric acid root treatment. I. Clinical and histologic observations six months postsurgery. J Periodontol 1983 Feb;54(2):67-76.
  15. Curtis JW, Mclain JB, Hutchinson RA. The incidence and severity of complications and pain following periodontal surgery. J Periodontol 1985 Oct;56(10):597-601.
  16. Ewers R, Goriwoda W, Schopper C, Moser D, Spassova E. Histologic findings at augmented bone areas supplied with two different bone substitute materials combined with sinus floor lifting: Report of one case. Clin Oral Impl Res 2004 Feb;15:96-100.
  17. Kenney EB, Lekovic V, Han T, Carranza FA, Dimitrijevic B. The use of a porous hydroxylapatite implant in periodontal defects. Clinical results after six months. J Periodontol 1985 Feb;56(1):82-88.
  18. Stahl SS, Froum SJ. Histologic and clinical responses to porous hydroxyapatite implants in human periodontal defects – 3 to 12 months postimplantation. J Periodontol 1987 Oct;58(10):689-695.
  19. Bowen JA, Mellonig IT, Gray JL, Towle HT. Comparison of decalcified freeze-dried bone allograft and porous particulate hydroxyapatite in human periodontal osseous defects. J Periodontol 1989 Dec;60(12):647-654.
  20. Turhani D, Cvikl B, Watzinger E, Weißenböck M, Yerit K, Thurnher D, Lauer G, Ewers R. In vitro growth and differentiation of osteoblast-like cells on hydroxyapatite ceramic granule calcified from red algae. J Oral Maxillofac Surg 2005 Jun;63(6):793-799.
  21. Reynolds MA. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic Review. Ann of Periodontol 2003 Dec;8(1):227-265.
  22. Low SB, King CJ, Krieger J. An evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodont Rest Dent 1997 Aug;17:359-367.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.